Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ofid/ofaa528 http://scihub22266oqcxt.onion/10.1093/ofid/ofaa528 33274249!7686662!33274249     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33274249&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Open+Forum+Infect+Dis 2020 ; 7 (11): ofaa528 Nephropedia Template TP {{tp|p=33274249|t=2020. COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020 |pdf=|usr=}}{{33274249}} gab.com Text COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020 JO: Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33274249 #FOAvip Using a coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1-June 30, 2020, received >/=1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased. Twit Text FOAVip COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020 ????Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33274249 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33274249 #FOAvip English Wikipedia <ref>{{Cite pmid|33274249}}</ref> COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020 #MMPMID33274249 Acosta AM; Mathis AL; Budnitz DS; Geller AI; Chai SJ; Alden NB; Meek J; Anderson EJ; Ryan P; Kim S; Como-Sabetti K; Torres S; Dufort E; Bennett NM; Billing LM; Sutton M; Keipp Talbot H; George A; Pham H; Hall AJ; Fry A; Garg S; Kim L Open Forum Infect Dis 2020[Nov]; 7 (11): ofaa528 PMID33274249show ga Using a coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1-June 30, 2020, received >/=1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased. ?COVID-19 Investigational Treatments in Use Among Hospitalized Patients(epmc).pdf DeepDyve Pubget Overpricing